A Study to Learn More About How Safe Darolutamide is Under Real-world Conditions in Participants With Metastatic Hormone-Sensitive Prostate Cancer

Condition:   Metastatic Hormone-sensitive Prostate Cancer (mHSPC) Intervention:   Other: No Intervention Sponsor:   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials